Echocardiography-Based Predictors of Outcomes in Hospitalized Patients With Decompensated Heart Failure (ECHO-DECOMP)

Recruiting Observational Study
Heart Failure
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
76 (estimated)
Sponsor
Istanbul University - Cerrahpasa · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Acute decompensated heart failure is a leading cause of hospitalization and is associated with high morbidity and mortality. Early risk stratification in this population is crucial for guiding treatment strategies and predicting short- and long-term clinical outcomes. Transthoracic echocardiography is routinely performed in patients hospitalized with acute decompensated heart failure and provides …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults aged ≥18 years. * Hospitalization due to acute decompensated heart failure. * Intravenous diuretic therapy deemed necessary by the treating cardiologist. * Predominant left-sided heart failure. * Provision of written informed consent prior to participation. Exclusion C…
Contacts

Aybike G Taşdelen Acar, MD

+905356955610

aybikegul.tasdelen@iuc.edu.tr

CONTACT

Ümit Acar, MD

+905424421411

umit.acar1@iuc.edu.tr

CONTACT